Zhu FC, Li YH, Guan XH, Hou LH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 2020 May 22. pii: S0140-6736(20)31208.
PMID: 32450106